Seer (NASDAQ:SEER) Shares Down 10%

Seer, Inc. (NASDAQ:SEER)’s stock price was down 10% on Thursday . The stock traded as low as $18.42 and last traded at $18.45. Approximately 8,344 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 516,812 shares. The stock had previously closed at $20.50.

Several analysts have weighed in on SEER shares. Cowen assumed coverage on Seer in a report on Friday, October 15th. They issued an “outperform” rating on the stock. Zacks Investment Research upgraded Seer from a “sell” rating to a “hold” rating in a research report on Wednesday.

The stock has a market capitalization of $1.21 billion and a P/E ratio of -14.20. The stock has a 50-day moving average price of $24.05 and a two-hundred day moving average price of $30.81.

Seer (NASDAQ:SEER) last issued its quarterly earnings data on Tuesday, November 9th. The company reported ($0.30) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.29) by ($0.01). The firm had revenue of $2.16 million during the quarter, compared to analysts’ expectations of $1.33 million. On average, sell-side analysts forecast that Seer, Inc. will post -1.19 EPS for the current year.

In other news, CFO David R. Horn sold 10,000 shares of the business’s stock in a transaction on Monday, November 1st. The stock was sold at an average price of $37.78, for a total value of $377,800.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Omead Ostadan sold 20,000 shares of the business’s stock in a transaction on Wednesday, December 15th. The stock was sold at an average price of $23.10, for a total value of $462,000.00. The disclosure for this sale can be found here. Insiders have sold 76,273 shares of company stock valued at $1,982,091 in the last quarter. 28.87% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of Seer by 36.3% in the second quarter. Vanguard Group Inc. now owns 888,926 shares of the company’s stock worth $29,139,000 after acquiring an additional 236,871 shares during the period. Alyeska Investment Group L.P. grew its holdings in Seer by 139.5% during the second quarter. Alyeska Investment Group L.P. now owns 176,034 shares of the company’s stock valued at $5,770,000 after purchasing an additional 102,548 shares during the period. Renaissance Technologies LLC bought a new stake in Seer during the second quarter valued at about $2,082,000. The Manufacturers Life Insurance Company grew its holdings in Seer by 7.0% during the second quarter. The Manufacturers Life Insurance Company now owns 8,570 shares of the company’s stock valued at $281,000 after purchasing an additional 559 shares during the period. Finally, Metropolitan Life Insurance Co NY grew its holdings in Seer by 103,840.0% during the second quarter. Metropolitan Life Insurance Co NY now owns 5,197 shares of the company’s stock valued at $170,000 after purchasing an additional 5,192 shares during the period. 84.71% of the stock is owned by institutional investors.

About Seer (NASDAQ:SEER)

Seer, Inc, a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome.

Featured Story: Why is insider trading harmful?

Receive News & Ratings for Seer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seer and related companies with MarketBeat.com's FREE daily email newsletter.